Calithera Biosciences, Inc.
CALADelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496671
Calithera Biosciences, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on May 26, 2023; 29 institutions reported holding it in 13F filings for Q2 2022, worth $4.44M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Calithera Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 77 | 1 | 67 | −9 |
| Shares | 46.9M | 133.2K | 45.3M | −1.51M (−3.2%) |
| Value | $99.0M | $279.0K | $100.1M | +$1.39M (+1.4%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Calithera Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace North America L.P. | 307,244 | $670.0K | 0.00% |
| Franklin Resources Inc | 133,200 | $290.0K | 0.00% |
| Tudor Investment Corp Et Al | 26,939 | $59.0K | 0.00% |
| Virtu Financial LLC | 17,788 | $39.0K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 12,202 | $27.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 2,200 | $5.00K | 0.00% |
Sold out (15)
Institutions that held Calithera Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Trust Advisors LP | 174,841 | $365.0K |
| Tibra Equities Europe Ltd | 158,500 | $331.0K |
| Susquehanna International Group, LLP | 110,252 | $230.0K |
| Walleye Trading LLC | 78,560 | $164.0K |
| Jane Street Group, LLC | 71,063 | $149.0K |
| Strategic Wealth Advisors Group, LLC | 40,600 | $85.0K |
| LMR Partners LLP | 35,136 | $73.0K |
| Boothbay Fund Management, LLC | 19,097 | $40.0K |
| Y-Intercept (Hong Kong) Ltd | 16,387 | $34.0K |
| Prudential Financial Inc | 13,913 | $29.0K |
| Royal Bank of Canada | 3,267 | $7.00K |
| Panagora Asset Management Inc | 2,559 | $5.00K |
| Cubist Systematic Strategies, LLC | 2,159 | $5.00K |
| New York State Common Retirement Fund | 569 | $1.00K |
| Deutsche Bank AG | 437 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Calithera Biosciences, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 133,200 | $279.0K |